Subscribe to Updates in Legal, Economic & Regulatory Affairs

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.




This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Thomas Saunders

Thomas Saunders, Partner, Seyfarth Shaw LLPPartner
Seyfarth Shaw LLP
Member of the Law Council

Thomas Saunders is a Partner at Seyfarth Shaw in Boston, Massachusetts, where he specializes in representing emerging medical technology, biotechnology/genetic engineering and pharmaceutical concerns, particularly as to patent prosecution, patent strategy, IP licensing matters and ANDA Paragraph IV opinions. His practice also includes interference practice, trademark and copyright matters, as well as cybersquatting domain name disputes. He is particularly active in jewelry design disputes. Mr. Saunders has a substantial background in biotechnology and chemical patent practice, facilitated by his graduate studies in physiology at Case Western Reserve University and Albany Medical College. Previously, he was partner at Brown Rudnick and has been in-house patent counsel in the pharmaceutical industry. Specifically, Mr. Saunders has worked with entrepreneurs in the biomedical field from the earliest steps. He has advised and coordinated efforts including incorporation, preparation of the initial patent portfolio, instituting confidentiality and employment agreement procedures. His input has continued through obtaining regulator services, FDA and CE efforts, marketing steps and beyond. Mr. Saunders has lectured and authored several publications including "Secrets of Successful (non) Litigation,” “Patents as a Cash Crop: Sowing, Growing, Reaping & Litigating,” and “Pharmaceutical Technology Licensing Specifics”. Mr. Saunders received his JD from Boston College. (This is me - Update Profile)


Employment History
2007 - present Partner
Seyfarth Shaw LLP
2002 - 2007 Partner
Brown, Rudnick, Berlack, Israels LLP
1990 - 2002 Partner
Lorusso & Loud

GLG NewsSM Analyses by Thomas Saunders(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
RIPENING INHIBITORS: ROSY FUTURE OR BRUISED FRUIT? | 12-21-2007
Author: Thomas Saunders, Partner, Seyfarth Shaw LLP

    Product shelf-life is a major economic concern for the agricultural industry.   The biological mechanism for regulating the ripening of fruits is mediated by ethylene.     Ethylene  management is addressed in three ways: 1) Ethylene...

Defending Knock-Offs: Head-to-head With Brand Names in Trademark, Copyright, and Internet Marketing | 03-01-2007
Author: Thomas Saunders, Partner, Seyfarth Shaw LLP

-Name Brands vs, Knock-Offs: Strategies and Counter-Strategies -Vulnerabilities of Name Brand Copyrights -Why the internet Knock-Off market will always exist

GLG InstituteSM Seminars with Thomas Saunders(?)

 
Thomas Saunders has not participated in any GLGi Seminars.
View all GLG InstituteSM Seminars in Legal, Economic & Regulatory Affairs

Request a project with Thomas Saunders








GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics